Type 1 Diabetes Efficacy Studies

Advantages of Evaluating Immunomodulatory Therapeutics In Vivo in Hu-PBMC NSG Mice to Investigate GVHD

$0.34 - $3.00

Select Options

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

$0.47 - $7.00

Select Options

Imiquimod Induced Psoriasis Efficacy Studies

$0.47 - $7.00

Select Options

Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

$0.81 - $9.00

Select Options

Investigating Type 1 Diabetes with Cutting-Edge Preclinical Mouse Models and Studies

$0.34 - $3.00

Select Options

Comprehensive Immunodeficient Suite

$1.51 - $6.00

Select Options

In Vivo Safety and Efficacy Platform for Immunotherapies

$0.47 - $7.00

Select Options

Studying CRS In A Diverse Population FAQS

$0.34 - $3.00

Select Options